Incidental Pulmonary Nodules Found on CT Scans

A pulmonary nodule is a rounded spot in the lung measuring 3 centimeters or less on a CT scan. Anything larger gets called a mass. Nodules are extremely common, and CT scanners have become good enough to see ones a few millimeters across that no earlier technology would have registered.

The great majority are not cancer. Most are scars from infections you had and recovered from years ago, small clusters of inflammation, or lymph nodes inside the lung. Fungal exposures common in parts of the country, healed pneumonia, and old granulomas account for a large share.

Almost everyone reading a nodule report wants one thing: when do I get scanned again, and what would change the plan. Radiologists answer that with one of two systems, and knowing which one is in play prevents most of the confusion.

If the nodule was found on a lung cancer screening CT

Lung-RADS applies. Each scan gets a category that maps directly to a follow-up interval.

ACR gives an estimated prevalence for each category — how often it comes up — but the v2022 table no longer prints a cancer probability beside it.

• Category 1 (negative) covers about 39 percent of exams and Category 2 (benign) about 45 percent. Both return in 12 months.
• Category 3 (probably benign) is about 9 percent of exams. Repeat low-dose CT in 6 months.
• Category 4A (suspicious) is about 4 percent. Repeat CT in 3 months, with PET/CT considered if there is a solid nodule or solid part 8 mm or larger.
• Category 4B (very suspicious) is about 2 percent, and 4X under 1 percent. These move to diagnostic chest CT, PET/CT, tissue sampling, or referral for further clinical evaluation.
• S modifier flags a significant finding unrelated to lung cancer, such as coronary calcification. ACR puts it at about 10 percent of exams.

Category 4A is a shorter leash, not a verdict. ACR's own rule says a 4A finding that is stable or smaller at the 3-month scan drops back to category 2.

If the nodule was found by accident

A nodule spotted on a CT ordered for chest pain, an injury, an abdominal problem, or a pre-surgical check is managed under the Fleischner Society criteria, which use different thresholds because the population is lower risk.

For a single solid nodule: under 6 mm in a low-risk person, no routine follow-up. Under 6 mm in a high-risk person, an optional scan at 12 months. Between 6 and 8 mm, a scan at 6 to 12 months; people at higher risk are scanned again at 18 to 24 months. Above 8 mm, a scan at 3 months, PET/CT, or sampling depending on the picture.

Subsolid and ground-glass nodules are followed longer, sometimes out to 5 years, because when they do turn out to be cancer they grow very slowly.

Fleischner explicitly does not apply if you are under 35, immunosuppressed, have a known cancer, or are in a screening program. If any of those fits, expect closer follow-up.

Size matters most, but it is not the only input.

Growth is the strongest single signal. A solid nodule holding the same size across scans a year or more apart is behaving benignly. That reasoning is weaker for subsolid and ground-glass nodules, which can sit unchanged for years and still turn out to be an indolent cancer, which is why they are watched for longer. This is exactly why intervals exist.

Density. Part-solid nodules carry higher cancer risk than solid nodules of the same size. Pure ground-glass nodules are usually indolent even when malignant.

Edges. Smooth, round borders lean benign. Spiculated or irregular edges lean suspicious.

Calcification pattern. Certain patterns, central, laminated, or popcorn, are reliably benign and end the discussion.

Location. Upper-lobe nodules are somewhat more likely to be malignant.

Your own risk. Age, smoking history, occupational exposures, and any prior cancer all shift the estimate.

Being told to come back in six months when a spot has been found in your lung feels like being asked to do nothing. It is not nothing. Serial imaging is a test in its own right, and for small nodules it is safer and more informative than the alternative. Biopsying a 7 mm nodule deep in the lung is technically hard and carries real risks including pneumothorax and bleeding, and a non-diagnostic sample leaves you no better informed.

Two practical things protect you. Make sure any prior chest imaging you have had is pulled for comparison, because a solid nodule unchanged over two years of imaging is generally taken as benign. That two-year rule does not extend to subsolid or ground-glass nodules, and it does not apply if you have a known cancer or a suppressed immune system, so ask the ordering clinician to confirm your own stopping point rather than assuming it. And get the follow-up on the calendar before you leave. The most common thing that goes wrong with lung nodules is not a missed diagnosis on the scan; it is a recommended repeat scan that never gets booked.

Serial scanning is the plan for a small nodule, but new symptoms while you wait are worth acting on rather than saving for the next appointment. A needle biopsy of the lung also carries its own short list of risks.

• Call 911 or go to an emergency department if you cough up more than a few teaspoons of blood, or you get sudden sharp chest pain with severe breathlessness in the days after a lung biopsy, which can mean the lung has collapsed.
• Call your care team the same day if you cough up any blood at all, even a streak, or coughing up blood comes with fever, dizziness or blood in your urine or stool.
• Call your care team within a day or two if a cough, chest discomfort or breathlessness is new since the nodule was found, or has clearly worsened between scans.

• MacMahon et al. 2017, Radiology (RSNA) — Fleischner Society guideline for incidental pulmonary nodules
• USPSTF: Lung cancer screening recommendation
• NCI: Lung Cancer Screening (PDQ) - Patient Version
• ACR Lung-RADS clinical resource page, including the v2022 assessment categories
• MedlinePlus: Lung needle biopsy
• MedlinePlus: Coughing up blood